×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

Ò©Îï¼ÁÁ¿ÓëЧӦ¹ØÏµ¡¢Ò©Îï×÷ÓûúÖÆÑо¿µÈҩЧѧÑо¿µÄÄÚÈÝ

2015-09-28
|
»á¼ûÁ¿£º

ҩЧѧÑо¿µÄÒ»Ñùƽ³£Ô­Ôò£ºËæ»ú¡¢±ÈÕÕ¡¢Öظ´
ҩЧѧÑо¿µÄ»ù±¾ÒªÁ죺ÌåÄÚÊÔÑé·¨ºÍÌåÍâÊÔÑé·¨£¬ÆäÖÐÐÂҩҩЧѧÊÔÑéÒÑÌåÄÚÊÔÑéΪÖ÷£¬ÌåÍâʵÑéΪ¸¨ ¡£

ҩЧѧÑо¿µÄ¸øÒ©ÒªÁ죺Ԥ·ÀÐÔ¸øÒ©¡¢ÖÎÁÆÐÔ¸øÒ©¡¢·ÀÖÎÁ¬ÏµµÄ¸øÒ©·½·¨


×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!×ðÁú¿­Ê±Ò©ÎïÇå¾²ÆÀ¼ÛЧÀÍ¡·¡·

Ñ¡ÓÃÒ»ÖÖÒÔÉ϶¯Îï¾ÙÐÐҩЧÊÔÑ飬ÿһ·½ÃæÒ©Àí×÷ÓÃҪѡÓÃ2~3ÖÖ¶¯ÎïÄ£×Ó»òÕßϸ°ûÄ£×ÓÀ´×ö ¡£

Ò©ÎïµÄ»ù±¾×÷ÓÃ
     1¡¢¸±×÷ÓãºÔÚÖÎÁƼÁÁ¿ÏÂÒ©Îﱬ·¢µÄÓëÖÎÁÆÄ¿µÄÎÞ¹ØµÄÆäËû·´Ó¦ ¡£
     2¡¢¶¾ÐÔ·´Ó¦£ºÒ©Îï¼ÁÁ¿¹ý´ó¡¢ÓÃҩʱ¼ä¹ý¾Ã»òÒ©ÎïÔÚÌåÄÚÐî»ý¹ý¶à±¬·¢µÄΣº¦ÐÔ²¡Àí·´Ó¦ ¡£
     3¡¢ºóÒÅ·´Ó¦£ºÍ£Ò©ºó£¬Ê£ÓàµÄÉúÎï·´Ó¦
     4¡¢Í£Ò©·´Ó¦£ºÍ£Ò©ºó¼²²¡¼Ó¾ç
     5¡¢Ê§³£·´Ó¦£ºÓֳƹýÃô·´Ó¦
     6¡¢ÌØÒìÖÊ·´Ó¦£º

Ò©Îï¼ÁÁ¿ÓëЧӦ¹ØÏµ
     ¼ÁÁ¿-ЧӦ¹ØÏµ£ºÒ©ÀíÐ§Ó¦Ëæ¼ÁÁ¿ÔÚÒ»¶¨¹æÄ£ÄÚ³ÉÕý±ÈÀýת±ä
     ¼ÁÁ¿·´Ó¦ÇúÏß

1¡¢Á¼·´Ó¦¹ØÏµ£ºÐ§Ó¦Ëæ¼ÁÁ¿µÄת±äÔÚÒ»¶¨¹æÄ£ÄÚ³ÊÕý±ÈÀýת±ä

×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!

Ò©Îï×÷ÓõÄÁ¿Ð§¹ØÏµÇúÏß


2¡¢ÖÊ·´Ó¦¹ØÏµ
Ò©ÀíЧӦ·ÖΪËÄÖÖ£ºÈ«¡¢ÎÞ¡¢ÑôÐÔ¡¢ÒõÐÔ

Ò©Îï×÷ÓûúÖÆÖ÷ÒªÄÚÈÝ£º
     1¡¢Àí»¯·´Ó¦£¨¿¹ËáÐÔ£©
     2¡¢¼ÓÈë»ò×ÌÈÅϸ°û´úлÀú³Ì
     3¡¢Ó°ÏìÐÄÀíÎïÖÊתÔË£¨ÀûÄòÒ©£©
     4¡¢¶ÔøµÄÓ°Ïì
     5¡¢×÷ÓÃÓÚϸ°ûĤµÄÀë×ÓͨµÀ
     6¡¢Ó°ÏìºËËã´úл
     7¡¢Ó°ÏìÃâÒß»úÖÆ
     8¡¢·ÇÌØÒìÐÔ×÷Óã¨È«ÂéÒ©£©
     9¡¢ÊÜÌå»úÖÆ

ҩЧѧÊÔÑéÄÚÈÝ£ºÌåÍâҩЧѧÊÔÑé¡¢ÌåÄÚҩЧѧÊÔÑé¡¢×÷ÓûúÖÆÑо¿
ҩЧѧÊÔÑéÔ­Ôò£ºÏÈÌåÄÚ£¬ºóÌåÍ⣻ÏÈÖ÷Òª£¬ºó´ÎÒª£»ÊÔÑ鼯»®ÒÀ¾Ý£¬Ìõ¼þ¼ò½é£»ÊÔÑéЧ¹û¡¢ÆÊÎö¡¢ÆÀ¼Û

³£ÓÃʵÑ鶯Î
      СÊó¡¢´óÊó¡¢ëàÊó¡¢µØÊó

      Íá¢È®¡¢ºï¡¢Ã¨¡¢Ð¡ÐÍÖí¡¢¼¦µÈ ¡£



ÁªÏµ×ðÁú¿­Ê±

Email:marketing@medicilon.com.cn

µç»°:8602158591500

ÍøÕ¾:www.medicilon.com.cn



    Ïà¹ØÄÚÈÝÍÆ¼ö

Ïà¹ØÐÂÎÅ
ҩЧѧÑо¿µÄÄÚÈÝÖ®Ò©ÀíЧӦµÄÁ½ÖØÐÔ
2015-11-03
ҩЧѧÑо¿ÊǶÔÒ©Îï¾ÙÐÐÓÐÓÃÐÔÆÀ¼Û£¬Ä¿µÄÔÚÓÚÆÊÎöÒ©Îï·ÀÖκÍÕï¶Ï¼²²¡µÄ»úÀí£¬Îª¿ª·¢ºÍÆÀ¼ÛÒ©ÎïÌṩ¿ÆÑ§ÒÀ¾Ý ¡£
CAR-T Ò©Îï·ÇÁÙ´²ÌåÄÚҩЧѧÑо¿³£ÓõÄÄ£×ÓÓÐÄÄЩ
2021-10-08
ÐÂÐÍ5-HT3ÊÜÌåÅäÌåÓÐÍûÓÃÓÚÖÎÁÆÉñ¾­¾«Éñ¼²²¡ºÍ賦µÀ¼²²¡£¬±¾Ñо¿ÖÐÒ©ÀíҩЧѧÑо¿Í¨¹ý×ðÁú¿­Ê±¾ÙÐÐ
2025-06-12
Droxytryptamine (5-HT; serotonin) 5-HT3 receptor is an excitatory ligandgated ion channel expressed in for example the brain and the gastrointestinal tract. CSTI-300 as a selective, high affinity 5-HT3 receptor partial agonist. CSTI-300 was examined alongside the selective 5-HT3 receptor antagonist alosetron (which is also currently marketed as a therapeutic for IBS-d). Sub-cutaneous application of 5-hydroxytryptophan (5-HTP; 10 mg/kg) markedly increased the rat¡¯s sensitivity to abdominal contractions. CSTI-300 and Alosetron displayed similar efficacy in a rodent in vivo model of IBS-d, measured by a reduction in colonic sensitivity. The experiments (Rat colon distension model of IBS-d) were carried out by Medicilon. The protocol complied with and was approved by the Institutional Animal Care and Use Committee and Medicilon is accredited by the NIH Office of laboratory Animal Welfare (OLAW) and AAALAC. Experiments (dog behavioural and emesis model) were performed by Medicilon. The protocol for the dog behavioural and emesis model complied with and was approved by the Institutional Animal Care and Use Committee.
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿